ImmunoGen planning follow-on
13:57 EDT 11 Jul 2012 | BioCentury
ImmunoGen Inc. (NASDAQ:IMGN) said late Wednesday it is planning a follow-on underwritten by Morgan Stanley and Jefferies. ImmunoGen was off $0.01 to $17.36 on Wednesday. The most advanced product using ImmunoGen's Targeted Antibody Payload (TAP) tech..
Original Article: ImmunoGen planning follow-on
More From BioPortfolio on "ImmunoGen planning follow-on"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
